Last reviewed · How we verify
Solid Tumors
Approved treatments
- Sitravatinib · Pfizer
Pipeline
- Encorafenib & Binimetinib Treatment · Pfizer Inc. — preclinical
- Binimetinib only treatment · Pfizer Inc. — preclinical
- Treatment of Encorafenib & Binimetinib & Cetuximab · Pfizer Inc. — preclinical
- Encorafenib only Treatment · Pfizer Inc. — preclinical
- Treatment of Encorafenib & Binimetinib & Ribociclib · Pfizer Inc. — preclinical
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Solid Tumors patent landscape — cliff calendar, originator estates, attackable patents
- Solid Tumors treatment landscape brief
- Solid Tumors treatment updates RSS
Frequently asked questions about Solid Tumors
What drugs treat Solid Tumors?
Tracked treatments include Sitravatinib.
What is the treatment for Solid Tumors?
Standard treatment for Solid Tumors includes Sitravatinib. See the treatment landscape page for first-line, second-line and salvage options.
What new drugs are in development for Solid Tumors?
5 pipeline drugs tracked. Top candidates: Encorafenib & Binimetinib Treatment, Binimetinib only treatment, Treatment of Encorafenib & Binimetinib & Cetuximab, Encorafenib only Treatment, Treatment of Encorafenib & Binimetinib & Ribociclib.
Related
- Treatment landscape: Solid Tumors patent cliff · Solid Tumors CI report
- Treatment: Sitravatinib · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing